Literature DB >> 17383479

Distraction osteogenesis and nonunion of the docking site: is there an ideal treatment option?

Nikolaos Giotakis1, Badri Narayan, Selvadurai Nayagam.   

Abstract

Docking sites are the result of a classic bone transport technique for dealing with bone loss. Union may prove to be the rate-limiting step in the duration of treatment. Strategies to improve union have focused on surgical manipulation such as immediate coaptation of the margins of the segmental defect in the process of acute shortening to prevent fibrocartilaginous capping of the ends of bone during transport. This procedure has the highest success rate for union but is limited by its effect on the limb's vascularity. Other techniques for improving union involve compression, alternate compression-distraction, and bone grafts, all of which induce union to a variable degree. The application of external stimulators and bone morphogenetic proteins, the use of which is supported in fracture healing and even regenerate formation, is as yet unproven at docking sites.

Entities:  

Mesh:

Year:  2007        PMID: 17383479     DOI: 10.1016/j.injury.2007.02.015

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  19 in total

1.  Pseudoaneurysm of the peroneal artery: an unusual complication of open docking site procedure in bone transport with Taylor Spatial Frame.

Authors:  Francesco Sala; Camilla Federica Salerno; Walter Albisetti
Journal:  Musculoskelet Surg       Date:  2011-08-05

2.  Clinical reliability of closed techniques and comparison with open strategies to achieve union at the docking site.

Authors:  Giovanni Lovisetti; Francesco Sala; Anna N Miller; Ahmed M Thabet; Vincenzo Zottola; Dario Capitani
Journal:  Int Orthop       Date:  2011-04-20       Impact factor: 3.075

Review 3.  The role of stem cells in fracture healing and nonunion.

Authors:  Hangama C Fayaz; Peter V Giannoudis; Mark S Vrahas; Raymond Malcolm Smith; Christopher Moran; Hans Christoph Pape; Christian Krettek; Jesse B Jupiter
Journal:  Int Orthop       Date:  2011-08-24       Impact factor: 3.075

4.  Bone regeneration and docking site healing after bone transport distraction osteogenesis in the canine mandible.

Authors:  Lucy K Nagashima; Michelle Rondon-Newby; Ibrahim E Zakhary; William W Nagy; Uriel Zapata; Paul C Dechow; Lynne A Opperman; Mohammed E Elsalanty
Journal:  J Oral Maxillofac Surg       Date:  2011-05-20       Impact factor: 1.895

5.  Methods to shorten the duration of an external fixator in the management of tibial infections.

Authors:  Khaled M Emara; Khaled Abd Al Ghafar; Mohamed Ahmed Al Kersh
Journal:  World J Orthop       Date:  2011-09-18

6.  Cost of external fixation vs external fixation then nailing in bone infection.

Authors:  Khaled Mohamed Emara; Ramy Ahmed Diab; Khaled Abd El Ghafar
Journal:  World J Orthop       Date:  2015-01-18

7.  The efficiency of internal fixation with bone grafting at docking sites after bone transport for treatment of large segmental tibial bone defects.

Authors:  Maimaiti Xiayimaierdan; Jinyong Huang; Chenchen Fan; Feiyu Cai; Yusupu Aihemaitijiang; Zengru Xie
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Double-level bone transport for large post-traumatic tibial bone defects: a single centre experience of sixteen cases.

Authors:  Yanlong Zhang; Yong Wang; Jun Di; Aqin Peng
Journal:  Int Orthop       Date:  2017-11-11       Impact factor: 3.075

9.  Infected bone defects in the lower limb. Management by means of a two-stage distraction osteogenesis protocol.

Authors:  César Salcedo Cánovas; Javier Martínez Ros; Antonio Ondoño Navarro; José Molina González; Alicia Hernández Torres; Encarnación Moral Escudero; Manuel Medina Quirós
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-02-08

Review 10.  The Ilizarov paradigm: thirty years with the Ilizarov method, current concerns and future research.

Authors:  Alexander V Gubin; Dmitry Y Borzunov; Tatiana A Malkova
Journal:  Int Orthop       Date:  2013-05-28       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.